Navigation Links
Synergy Research Group Releases Q2, 2014 Orange Paper
Date:8/6/2014

Moscow, Russia (PRWEB) August 06, 2014

Synergy Research Group has released its Q2, 2014 Orange Paper. Published since 2006, the Synergy Orange Paper gives an unbiased and detailed view of the state of clinical trials in Russia. The report, which is issued quarterly, gives a strategic overview and drills down into additional data, such as the number of trials, top companies that initiated studies and their country of origin.

The Synergy Orange Paper is relied on by the local and international life science and business community involved in clinical trials. The report compares current data with previous numbers so readers can see year-over-year changes.

“We started publishing the Orange Paper because clinical research in Russia is a dynamic marketplace that is increasingly attractive globally,” said Igor Stefanov, CEO of Synergy Research Group. “Having detailed information on the state of clinical research in the region allows sponsors to make better informed decisions."

Russia has large patient populations across high-demand therapeutic areas such as oncology, central nervous system, and cardiovascular. Additionally, the per-patient spend on pharmaceuticals is expected to more than double by 2016, growing to more than four billion dollars annually.

“Since we started publishing the Synergy Orange Paper, we have had a lot of feedback from all over the world telling us how much people rely on it,” Stefanov continued. “We feel it is well worth the investment we put into creating it.”

Synergy Research Group leads the Russian market in full-service contract research. The company has senior management teams with deep domain expertise, as well as executives with experience working inside regulatory agencies who speed the approval processes.

About Synergy Research Group
Synergy Research Group, http://www.synrg-pharm.com, is a full-service Contract Research Organization (CRO) founded in 2002 that delivers its Troika Promise of Speed, Cost and Quality to clients. Synergy provides a full range of CRO services to help global pharmaceutical and biotechnology companies conduct successful and cost-effective clinical trials. The company provides transparency, access and control to sponsors during the entire project through its cloud-based monitoring system. Synergy has locations in Moscow, Saint-Petersburg, Novosibirsk, Yekaterinburg, Perm, Krasnodar, Almaty and Astana (Kazakhstan) and Kyiv (Ukraine). The company's headquarters are in Moscow.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12076661.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. SYNERGY HomeCare Offers Free Home Safety Assessments
2. Moffitt researcher investigates 2-drug synergy to treat drug-resistant chronic myeloid leukemia
3. Phoenix Synergy Discusses securing computer networks at the AZPMA conference in Las Vegas
4. Synergy Wellness & Weight Releases Article on Healthcare Prevention
5. Announcement: NutriSynergy, LLC is Offering a Webinar Presentation with Jason Bartels
6. Voltari Corporation Selects Intacct Cloud Financials and Synergy Business Solutions for New Accounting System and Implementation
7. Searching for therapeutic synergy in primary effusion lymphoma
8. Synergy Lifestyle Center Brings New Age Management Program to Bakersfield, CA
9. MEDIA ALERT: Imprivata and Dell Wyse to Discuss Benefits of Desktop Virtualization and Single Sign-On in Healthcare at Citrix Synergy
10. SYNERGY HomeCare Wins Two Prestigious Endorsements
11. NuScale Power Selects Synergy Business Solutions to Implement Microsoft Dynamics SL Project-accounting and Financial Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... , ... June 27, 2017 , ... DrugDev ... is whether they can trust the sponsor to pay them correctly and on time. ... and CROs establish payment strategies that encourage sites to work on their studies. , ...
(Date:6/27/2017)... , ... June 27, 2017 , ... The Congressional Budget ... to repeal and replace the 2010 Patient Protection and Affordable Care Act (ACA), would ... what would be expected under current law. , More than 20 million Americans have ...
(Date:6/27/2017)... ... June 27, 2017 , ... A January 18th article on ... staggering $6.81 billion by the year 2024 according to a new report. The article ... those made from titanium. Los Angeles area clinic Beverly Hills Periodontics & Dental Implant ...
(Date:6/27/2017)... York, NY (PRWEB) , ... June 27, 2017 ... ... and marketing experts to contribute to an upcoming case studies guidebook. This guidebook ... her organization. , This book will include articles, case studies and how-to’s that ...
(Date:6/27/2017)... CT (PRWEB) , ... June 27, 2017 , ... Dr. ... the recent renovation of his practice, Advanced Periodontics and Dental Implant Center of Connecticut. ... increased the administrative and waiting areas. The renovations are intended to improve patient comfort ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... , June 14, 2017  In 2016, ... Creative Startups pitch competition and came away with ... platform is described by Forbes as "entering the life ... Medical Association as teaching "empathy to medical professionals in ... startup was recently named a finalist for the Department ...
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... , June 7, 2017 Endo International plc ... 7, 2017, the Hon. Joseph R. Goodwin , ... West Virginia , entered a case ... Pelvic Repair System Products Liability Litigation (the "MDL") that ... cases to provide expert disclosures on specific causation within ...
Breaking Medicine Technology: